• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[应用慢性阻塞性肺疾病与哮喘生理学评分评估慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者急性加重严重程度的价值研究]

[The study on the value of using the chronic obstructive pulmonary disease and asthma physiology score to assess the severity of acute exacerbation in patients with chronic obstructive pulmonary disease complicated by type II respiratory failure].

作者信息

Zhang Mu-cheng, Wang Zheng-guang, Cheng Jin-xia, Wang Jian-lei, Zheng Shao-peng

机构信息

Intensive Care Unit, People's Hospital of Huangshan Affiliated to Wannan Medical College, Huangshan 245000, Anhui, China.

出版信息

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 May;22(5):275-8.

PMID:20519075
Abstract

OBJECTIVE

To explore the value of the chronic obstructive pulmonary disease (COPD) and asthma physiology score (CAPS) in evaluating the severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated by type II respiratory failure.

METHODS

Eighty-two cases with AECOPD complicated by type II respiratory failure between January 2005 and March 2009 were retrospectively analyzed. The severity in survivors and non-survivors was evaluated by CAPS and acute physiology and chronic health evaluation system (APACHE II score, APACHE III score), and retrospective and statistical analyses of all data were performed.

RESULTS

CAPS, APACHE II score, APACHE III score, duration of invasive positive pressure ventilation (IPPV) and days in intensive care unit of 19 cases in the death group were 34.21+/-9.89, 22.53+/-7.49, 75.11+/-18.07, (25.06+/-24.64) days, (32.42+/-25.49) days , respectively, while 63 cases of the survival group were 27.41+/-8.15, 18.65+/-5.34, 64.11+/-15.92, (5.23+/-5.50) days, (12.51+/-20.70) days, respectively, and there were significant differences between two groups (P<0.05 or P<0.01). The areas under receiver operating characteristic (ROC) curves of CAPS, APACHE II score and APACHE III score were 0.712 (P=0.005), 0.654 (P=0.043) and 0.655 (P=0.042), respectively. When CAPS score was 30.5, Youden index was the highest (0.435). The mortality rate had a positive correlation with CAPS. When the CAPS score was over 30, there was a tendency of increase in mortality rate.

CONCLUSION

CAPS is very useful to evaluate the severity and prognosis of patients with AECOPD complicated by type II respiratory failure. It is easy to perform, and better than APACHE II and APACHE III.

摘要

目的

探讨慢性阻塞性肺疾病与哮喘生理学评分(CAPS)在评估慢性阻塞性肺疾病急性加重期(AECOPD)合并Ⅱ型呼吸衰竭患者严重程度及预后中的价值。

方法

回顾性分析2005年1月至2009年3月期间82例AECOPD合并Ⅱ型呼吸衰竭患者的资料。采用CAPS、急性生理学与慢性健康状况评价系统(APACHEⅡ评分、APACHEⅢ评分)评估存活患者与死亡患者的严重程度,并对所有数据进行回顾性统计分析。

结果

死亡组19例患者的CAPS、APACHEⅡ评分、APACHEⅢ评分、有创正压通气(IPPV)时间及重症监护病房住院天数分别为34.21±9.89、22.53±7.49、75.11±18.07、(25.06±24.64)天、(32.42±25.49)天,存活组63例患者分别为27.41±8.15、18.65±5.34、64.11±15.92、(5.23±5.50)天、(12.51±20.70)天,两组比较差异有统计学意义(P<0.05或P<0.01)。CAPS、APACHEⅡ评分及APACHEⅢ评分的受试者工作特征(ROC)曲线下面积分别为0.712(P=0.005)、0.654(P=0.043)、0.655(P=0.042)。当CAPS评分为30.5时,约登指数最高(0.435)。死亡率与CAPS呈正相关。当CAPS评分>30分时,死亡率有上升趋势。

结论

CAPS对评估AECOPD合并Ⅱ型呼吸衰竭患者的严重程度及预后有重要价值,操作简便,优于APACHEⅡ和APACHEⅢ评分。

相似文献

1
[The study on the value of using the chronic obstructive pulmonary disease and asthma physiology score to assess the severity of acute exacerbation in patients with chronic obstructive pulmonary disease complicated by type II respiratory failure].[应用慢性阻塞性肺疾病与哮喘生理学评分评估慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者急性加重严重程度的价值研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 May;22(5):275-8.
2
A new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology Score.一种用于阻塞性气道疾病加重期患者的急性生理紊乱新指标:慢性阻塞性肺疾病和哮喘生理评分。
Respir Med. 2007 Sep;101(9):1994-2002. doi: 10.1016/j.rmed.2007.04.002. Epub 2007 Jul 9.
3
Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.急性非酸中毒加重后从内科病房出院的轻度慢性阻塞性肺疾病老年患者6个月死亡率的预测因素
J Am Geriatr Soc. 2008 May;56(5):909-13. doi: 10.1111/j.1532-5415.2008.01683.x. Epub 2008 Apr 1.
4
Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation.慢性阻塞性肺疾病急性加重期无创通气的早期和晚期失败
Eur J Clin Invest. 2005 Jun;35(6):404-9. doi: 10.1111/j.1365-2362.2005.01509.x.
5
Prevalence and prognostic role of cardiovascular complications in patients with exacerbation of chronic obstructive pulmonary disease admitted to Italian respiratory intensive care units.意大利呼吸重症监护病房收治的慢性阻塞性肺疾病急性加重患者心血管并发症的患病率及预后作用
Ital Heart J. 2004 Dec;5(12):932-8.
6
Five-year outcome in COPD patients after their first episode of acute exacerbation treated with non-invasive ventilation.慢性阻塞性肺疾病患者首次急性加重后接受无创通气治疗的 5 年结局。
Respirology. 2010 Oct;15(7):1084-91. doi: 10.1111/j.1440-1843.2010.01795.x. Epub 2010 Jun 21.
7
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.慢性阻塞性肺疾病(COPD)所致慢性呼吸衰竭(CRF)的肺康复疗效:毛杰里研究
Respir Med. 2007 Dec;101(12):2447-53. doi: 10.1016/j.rmed.2007.07.016. Epub 2007 Aug 28.
8
Noninvasive ventilation in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease who refused endotracheal intubation.慢性阻塞性肺疾病急性高碳酸血症加重且拒绝气管插管患者的无创通气
Crit Care Med. 2004 Feb;32(2):372-7. doi: 10.1097/01.CCM.0000108879.86838.4F.
9
[Use of acute physiology and chronic health evaluation III in evaluating prognosis of chronic obstructive pulmonary disease in elderly patients on mechanical ventilation].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Jun;18(6):373-5.
10
Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.氨基末端脑钠肽前体用于诊断既往有阻塞性气道疾病患者的急性心力衰竭。
Ann Emerg Med. 2006 Jul;48(1):66-74. doi: 10.1016/j.annemergmed.2005.12.022. Epub 2006 Feb 17.

引用本文的文献

1
The arrival ward requiring help by wheelchair or medical cart, arterial oxygenation index, age, albumin and neutrophil count score: Predicting in-hospital mortality in Chinese patients with acute exacerbations of chronic obstructive pulmonary disease.需要轮椅或医用推车帮助才能抵达病房、动脉血氧合指数、年龄、白蛋白和中性粒细胞计数评分:预测中国慢性阻塞性肺疾病急性加重患者的住院死亡率。
Chron Respir Dis. 2023 Jan-Dec;20:14799731231197226. doi: 10.1177/14799731231197226.
2
Prognostic Role of Chronic Obstructive Pulmonary Disease and Asthma Physiology Score for in-Hospital and 1-year Mortality in Patients with Acute Exacerbations of COPD.慢性阻塞性肺疾病和哮喘生理评分对慢性阻塞性肺疾病急性加重患者住院及1年死亡率的预后作用
Can Respir J. 2022 Apr 25;2022:4110562. doi: 10.1155/2022/4110562. eCollection 2022.
3
The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review.高流量鼻导管疗法在 COPD 合并 II 型呼吸衰竭患者中的疗效和安全性:一项荟萃分析和系统评价。
Eur J Med Res. 2021 Oct 14;26(1):122. doi: 10.1186/s40001-021-00587-7.